ALEC vs ALNY · rev $4.4M vs P/E 76, rev $1.29B
Alector Inc (ALEC) versus Alnylam Pharmaceuticals Inc (ALNY) — a side-by-side from cached financials, not a winner call.
Alector Inc (ALEC) is a biotechnology company listed on US.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Latest reported ALEC revenue for 2026-06-30 was $4.4M. Net income was -$45.9M. ALEC currently screens at market cap $216.5M.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
ALEC currently screens at market cap $216.5M. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Not investment advice. Open the ALEC and ALNY stock pages for the full models.
Not investment advice.